European court decision has big implications for stem cell research

aCJEU

 

Brüstle v. Greenpeace, decided by the Court of Justice of the European Union, or CJEU, on October 18, 2011, changes the landscape of patent law in the European Union. Brüstle was referred from the Bundesgerichtshof, Germany’s Federal Court of Justice, to the CJEU for guidance on the meaning of “human embryo” in Directive 98/44/EC on the legal protection of biotechnological inventions (hereinafter Directive).

View the original article here: European Court Decision has Big Implications for Stem Cell Research

Related article:  Viewpoint: Simple disclosure—not fancy logo—is what GMO labeling needs
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend